The effect of activating mutations on dimerization, tyrosine phosphorylation and internalization of the macrophage colony stimulating factor receptor

K Carlberg and L Rohrschneider

Fred Hutchinson Cancer Research Center, Seattle, Washington 98104.

Oncogenic activation of the macrophage colony stimulating factor (M- CSF) receptor (c-Fms) requires mutation or truncation of the carboxyl terminus and specific amino acid substitutions in or near the fourth immunoglobulin (Ig)-like loop in the extracellular domain. Using a murine c-Fms system, we investigated the effect of C-terminal truncation, substitutions at amino acids 301 and 374 in the fourth Ig- like loop of the extracellular domain, or the combined mutations on individual steps in receptor activation. The mutations at amino acids 301 and 374 were necessary, but not sufficient, for receptor dimerization in the absence of M-CSF. Only receptors with a truncated C- terminus as well as the extracellular domain mutations dimerized efficiently in the absence of M-CSF, suggesting that the C-terminus of c-Fms also regulates receptor oligomerization. Truncation of the C- terminus alone did not cause receptor dimerization and did not activate the kinase enzymatic activity. Thus, truncation of the C-terminus did not activate receptor monomers in cis. Receptors with both a truncated C-terminus and the extracellular domain mutations underwent ligand- independent aggregation, transphosphorylation, and phosphorylation of cellular proteins, followed by rapid internalization and degradation. These results suggest that M-CSF binding to c-Fms initiates activation by inducing conformational changes in both the cytoplasmic C-terminal domain and the fourth Ig-like loop of the extracellular domain, leading to the formation of stable receptor dimers.

Volume 5, Issue 1, pp. 81-95, 01/01/1994
Copyright © 1994 by The American Society for Cell Biology

This article has been cited by other articles:

				T. M. Kohl, S. Schnittger, J. W. Ellwart, W. Hiddemann, and K. Spiekermann KIT exon 8 mutations associated with core-binding factor (CBF)-acute myeloid leukemia (AML) cause hyperactivation of the receptor in response to stem cell factor Blood, April 15, 2005; 105(8): 3319 - 3321. [Abstract] [Full Text] [PDF]

				I. K. Quigley, J. L. Manuel, R. A. Roberts, R. J. Nuckels, E. R. Herrington, E. L. MacDonald, and D. M. Parichy Evolutionary diversification of pigment pattern in Danio fishes: differential fms dependence and stripe loss in D. albolineatus Development, January 1, 2005; 132(1): 89 - 104. [Abstract] [Full Text] [PDF]

				O. M. Mitrasinovic and G. M. Murphy Jr. Accelerated Phagocytosis of Amyloid-beta by Mouse and Human Microglia Overexpressing the Macrophage Colony-stimulating Factor Receptor J. Biol. Chem., August 9, 2002; 277(33): 29889 - 29896. [Abstract] [Full Text] [PDF]

				Y. Liu, B. Jenkins, J. L. Shin, and L. R. Rohrschneider Scaffolding Protein Gab2 Mediates Differentiation Signaling Downstream of Fms Receptor Tyrosine Kinase Mol. Cell. Biol., May 1, 2001; 21(9): 3047 - 3056. [Abstract] [Full Text]

				S. C. Robertson, A. N. Meyer, K. C. Hart, B. D. Galvin, M. K. Webster, and D. J. Donoghue Activating mutations in the extracellular domain of the fibroblast growth factor receptor 2 function by disruption of the disulfide bond in the third immunoglobulin-like domain PNAS, April 14, 1998; 95(8): 4567 - 4572. [Abstract] [Full Text] [PDF]

				K. Carlberg and L. R. Rohrschneider Characterization of a Novel Tyrosine Phosphorylated 100-kDa Protein That Binds to SHP-2 and Phosphatidylinositol 3'-Kinase in Myeloid Cells J. Biol. Chem., June 20, 1997; 272(25): 15943 - 15950. [Abstract] [Full Text] [PDF]

				S. J. Geier, P. A. Algate, K. Carlberg, D. Flowers, C. Friedman, B. Trask, and L. R. Rohrschneider The Human SHIP Gene Is Differentially Expressed in Cell Lineages of the Bone Marrow and Blood Blood, March 15, 1997; 89(6): 1876 - 1885. [Abstract] [Full Text] [PDF]

				J. L.-K. Chan, M. Lai, and L.-H. Wang Effect of Dimerization on Signal Transduction and Biological Function of Oncogenic Ros, Insulin, and Insulin-like Growth Factor I Receptors J. Biol. Chem., January 3, 1997; 272(1): 146 - 153. [Abstract] [Full Text] [PDF]

				S. Bose, J. Feix, S. Seetharam, and B. Seetharam Dimerization of Transcobalamin II Receptor J. Biol. Chem., May 17, 1996; 271(20): 11718 - 11725. [Abstract] [Full Text] [PDF]

				M N Lioubin, P A Algate, S Tsai, K Carlberg, A Aebersold, and L R Rohrschneider p150Ship, a signal transduction molecule with inositol polyphosphate-5-phosphatase activity. Genes & Dev., May 1, 1996; 10(9): 1084 - 1095. [Abstract] [PDF]

				O. M. Mitrasinovic, G. V. Perez, F. Zhao, Y. L. Lee, C. Poon, and G. M. Murphy Jr. Overexpression of Macrophage Colony-stimulating Factor Receptor on Microglial Cells Induces an Inflammatory Response J. Biol. Chem., August 3, 2001; 276(32): 30142 - 30149. [Abstract] [Full Text] [PDF]